CME

CME


Latest Episodes

Hiding in Plain Sight: A Multidisciplinary Effort to Improve Identification and Treatment of Thyroid Eye Disease
December 20, 2023

Host: Andrea Kossler, MD, FACS Host: Jennifer Murdock, MD Guest: Eve Bloomgarden, MD Thyroid eye disease (TED) is the most common noninfectious, autoimmune disease that leads to inflammation and enlargement of the orbital and retro-orbit

Treating ATTR-CM With a Novel Therapeutic Approach: Understanding the ATTRibutes to Success
December 11, 2023

Host: Martha Grogan, MD, FACP, FACC Guest: Marianna Fontana, MD Guest: Nitasha Sarswat, MD Once considered rare and untreatable, amyloid transthyretin (ATTR) amyloidosis with cardiomyopathy (ATTR-CM) has increased in incidence over the l

Keeping Pace in Lung Cancer - Breaking Barriers: Advances in Treating EGFR Exon 20 Insertions in NSCLC
December 11, 2023

Host: Heather Wakelee, MD, FASCO Guest: Lyudmila Bazhenova, MD We now have FDA approved targeted therapies to treat NSCLC with EGFR exon 20 insertion mutations. Drs. Wakelee and Bazhenova discuss the most current data on both approved therap

KOL Knockout™: Cancer Pain Management Edition
December 05, 2023

Host: Pranshu Mohindra, MD Guest: Melissa Teply, MD Guest: Judith Paice, PhD, RN Guest: Fionnuala Crowley, MD This enduring program of the live-virtual symposium will focus on the challenges of managing cancer pain using the Evolve K

Migraine and Women's Health: Migraine and the Whole Female Patient
December 05, 2023

Host: Jessica Ailani, MD Guest: Dawn C. Buse, PhD Upwards of 47 million people in the U.S. suffer from migraines, often accompanied by widespread personal, professional, and social disabilities. Though a similar prevalence is initially obser

Postpartum Depression: A Significant Burden and a Novel Approach to Treatment
December 05, 2023

Host: Lee Shulman MD, FACOG, FACMG Guest: Kristina Deligiannidis, MD The recent development and approval of two neuroactive steroids is likely to change the treatment paradigm for moderate to severe postpartum depression (PPD). These agents

Addressing Issues of CV Mortality in Clinical Trials with IV Iron: Are We Still Getting a Medical Benefit?
December 01, 2023

Host: Stefan D. Anker, MD, PhD Guest: John Cleland, MD Guest: Piotr Ponikowski, MD, PhD, FESC, FHFA Iron deficiency is a common heart failure comorbidity with a negative impact on patients quality of life and mortality. Recent world eve

Making a Difference: Patient-Centered Ulcerative Colitis Care in the Era of JAK Inhibitors and S1P Modulators
November 29, 2023

Guest: Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI Guest: Sophie M. Balzora, MD Guest: Latonia Ward, M.Min The goal of this program is to improve the overall management of patients with ulcerative colitis (UC). Specifically, we aim to impr

Building Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterologists
November 29, 2023

Host: Kimberly A. Brown, MD This chairmans perspective highlights the role of gastroenterologists in improving patient care and outcomes and will increase their awareness of NAFLD/NASH. Dr. Kimberly Brown takes a deep dive into late-stage clini

Hyperkalemia in CKD and HFrEF…What Am I Missing?
November 17, 2023

Host: George L. Bakris, MD, FAHA, FASN Guest: David Bushinsky, MD Guest: Lars Lund, MD Hyperkalemia is a limiting factor when treating patients with heart failure and CKD on RAASi therapy. Its especially challenging when these patients